Cannabis Life In Australia

Cannabis Life (Australia)

 

 On the 26th September 2016 the Australian Government legalised the commercial production and supply of medicinal cannabis in Australia. This change provides access to medicinal cannabis in Australia for patients suffering from HIV, Epilepsy, Multiple Sclerosis, Cancer and other associated medical conditions.

With the exception of one product (Nabiximols), medicinal cannabis products are not registered medicines in Australia, and none are subsidized through the Pharmaceutical Benefits Scheme (PBS), so they can only be accessed through special pathways available for unapproved medicines.

A variety of products are currently available through these pathways, via import from Canada or Europe. These include raw (botanical) cannabis which may be vaporized for medicinal purposes, as well as oils, liquids and oral sprays. Some products have also been developed for direct application to the skin (gels).

Similar products made from locally grown medicinal cannabis are expected to become available during 2018. Medicinal cannabis can only be prescribed by a registered medical practitioner after a thorough assessment to decide if the treatment is appropriate for the patient’s condition and individual circumstances.

If a doctor decides that a medicinal cannabis product is suitable for the patient, they must apply for approval to prescribe it under the applicable state or territory laws. Rules relating to medicinal cannabis products vary between states and territories and could affect whether or not medicinal cannabis can be prescribed.

Individual patients cannot apply to the TGA for access to medicinal cannabis products.

If you have a prescription and require assistance in obtaining medicinal cannabis products please contact us on info@cannabislife.com.au.